Two drugs together kill small cell lung cancer in the laboratory
A Duke study pairs an approved leukemia drug with an ATR inhibitor to kill metastatic small cell lung cancer cells, with the Lan Lab on the DNA repair work.
Notices
News
Read the news of the lab. The newest post stands first.
Ultrasound-Activated Microbubbles Deliver OPROTACs Directly Into Cancer Cells
A Duke team developed SonoPIN, an ultrasound-based platform that opens temporary pores in cancer cells to deliver large protein-degrading drugs with high efficiency and selectivity.
Mary Kay Ash Foundation grant for a TRDMT1 drug in ovarian and breast cancer
The Mary Kay Ash Charitable Foundation funds the lab's work on the mRNA methyltransferase TRDMT1 in ovarian and breast cancer.
A Harrington award backs the lab's mRNA methyltransferase drugs
Duke reported that the Harrington Discovery Institute supports the lab's work on compounds that act against an mRNA methyltransferase.
Li Lan elected to the American Society for Clinical Investigation
The American Society for Clinical Investigation elected Dr. Li Lan, one of four Duke School of Medicine faculty in a class of one hundred.
The Lan Lab joins Molecular Genetics and Microbiology at Duke
Duke named Dr. Li Lan among the newest faculty of the Department of Molecular Genetics and Microbiology, after the lab moved from Boston.
DNA repair gets into the RNA world: the MGM seminar at Duke
Dr. Li Lan gave a special seminar to the Duke Department of Molecular Genetics and Microbiology on the place of RNA in DNA repair.
Harrington Discovery Institute names Li Lan a Scholar-Innovator
The Harrington Discovery Institute placed Dr. Li Lan in its 2022 class of Scholar-Innovators, for a drug program against an mRNA methyltransferase.